A stable busulfan injection

A busulfan injection and a technology for the busulfan injection, which are applied in the field of busulfan injection, can solve the problems of reducing drug efficacy, drug waste, increasing costs, etc., and achieve the effects of safety in the preparation process, improving stability and ensuring safety.

Active Publication Date: 2015-08-12
SICHUAN CREDIT PHARMA +1
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are ester bonds that are easily hydrolyzed in the structural formula of busulfan, and are easily degraded by water to produce toxic tetrahydrofuran and methanesulfonic acid, which not only reduces the curative effect of the drug, but also increases the toxicity and irritation of the drug. The clinical application of Busulfan has buried a great hidden danger, so the water content in the preparation process of Busulfan must be strictly controlled
However, the solubilizer polyethylene glycol 400 in the existing injections is extremely easy to absorb water, and the inevitable environmental exposure in the production process will cause a large amount of water absorption, and polyethylene glycol 400, N, N-dimethylacetamide Or the trace amount of moisture carried by the active ingredients of the drug itself is enough to affect the stability of the product
At the same time, the busulfan injection prepared by the existing method cannot be stored for a long time, which not only brings great inconvenience to clinical medication, increases the risk of use, but also greatly increases the production cost of the drug
Because, when the produced medicine cannot be sold and used in a short period of time, it will quickly deteriorate and cannot be used any longer, and can only be destroyed, which will lead to a large amount of waste of medicine and further increase the cost
[0004] The inventor’s previous Chinese patent application (CN102151257A) disclosed a busulfan injection, which improved the stability of the busulfan injection by adding an organic acid or its alkali metal or alkaline earth metal salt as a stabilizer, but , due to the addition of chemical stabilizers, the busulfan injection is inconsistent with the existing drug standards, resulting in a long research and improvement process for the preparation to be approved for clinical use
[0005] So far, no studies and reports have been found on busulfan injections that meet the current busulfan drug standards and have drug safety and long-term storage stability

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A stable busulfan injection
  • A stable busulfan injection
  • A stable busulfan injection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] (1) Take 60mg of busulfan, and dissolve busulfan in 10ml of a mixed solvent of N,N-dimethylacetamide and polyethylene glycol 400 with a volume ratio of 33:67 at a controlled temperature of 20°C; (2 ) was filtered through a 0.45 μm microporous membrane, and the filtrate was filtered through a 0.22 μm microporous membrane for aseptic filling to obtain busulfan injection.

[0044] In the preparation method of the present invention, the humidity control of the working environment refers to the prior art.

Embodiment 2

[0046] (1) Take 60mg of busulfan, and dissolve busulfan in 10ml of a mixed solvent of N,N-dimethylacetamide and polyethylene glycol 400 with a volume ratio of 33:67 at a controlled temperature of 16°C; (2 ) with a 0.45 μm microporous membrane filter. Take the filtrate, filter it with a 0.22 μm microporous membrane and fill it aseptically to obtain busulfan injection.

Embodiment 3

[0048] Take N,N-dimethylacetamide and polyethylene glycol 400 (the volume ratio of the two solvents is shown in Table 1), mix well, and then fill the mixed solvent with nitrogen to achieve saturation (in order to ensure that the nitrogen is saturated, it may appear After continuous uniform air bubbles, continue to fill with nitrogen for 5 minutes). Add 60 mg of busulfan raw material to the mixed solvent, stir to dissolve, control the temperature at 16° C. during the dissolution process, and filter with a 0.45 μm microporous membrane. Take the filtrate, filter it with a 0.22 μm microporous membrane, and then continue to fill the mixed solvent with nitrogen to achieve saturation until continuous and uniform bubbles appear, and this state lasts for 5 minutes. Aseptic filling.

[0049] Table 1 prepares the solvent ratio and consumption selection of busulfan injection

[0050]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
Login to view more

Abstract

The invention provides a busulfan injection which is simple in prescription and stable in quality. The injection is prepared by the followings method: (1), dissolving busulfan into a mixed solvent of N, N-dimethyl acetamide and polyethylene glycol 400 in a volume ratio of (17-57):(83-43) to obtain a busulfan solution with concentration of 1mg / mL-7.5mg / mL; and (2), filtering and filling in a sterile manner, wherein in the dissolving process of the step (1), the temperature of the solution is 4 DEG C-25 DEG C, or / and inert gases are charged in an operation process until the solution is saturated. Not only is stability of the busulfan injection obtained by the preparation method disclosed by the invention improved, but also the safety of the injection after long-time storage is effectively ensured. Meanwhile, other substances or other chemical components are not introduced in the preparation process, so that the medication safety is ensured, and the drug cost is also lowered.

Description

technical field [0001] The invention relates to a preparation method of busulfan injection and the busulfan injection prepared by the method, belonging to the field of pharmaceutical preparations. Background technique [0002] Busulfan is a dimethylsulfonate bifunctional alkylating agent, which was first discovered in 1953. In terms of mechanism of action, busulfan is a cytotoxic antineoplastic drug. After entering the human body, its sulfonate group will undergo alkylation with guanine in tumor cells, interfering with the formation of tumor cell genetic material. , thereby inhibiting the growth of tumor cells. Busulfan is mainly suitable for proliferative diseases of blood and bone marrow, especially for chronic myeloid leukemia, essential thrombocythemia, polycythemia vera, primary myelofibrosis and other diseases. However, due to the poor solubility of busulfan, especially the worst in water solubility, it is difficult to absorb after oral administration, and the dose r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/08A61K31/255A61K47/34A61K47/18A61P35/02A61P7/00A61K47/10
Inventor 傅霖李文婕陈刚
Owner SICHUAN CREDIT PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products